You are here:
USE OF AMPHOTERICIN B FOR DIFFERENTIATING EUKARYOTIC FROM PROKARYOTIC ACTIVITY IN MIXED MICROBIAL SAMPLES
Citation:
Lewis, D. AND J. Hamala. USE OF AMPHOTERICIN B FOR DIFFERENTIATING EUKARYOTIC FROM PROKARYOTIC ACTIVITY IN MIXED MICROBIAL SAMPLES. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-87/205 (NTIS PB88170535).
Description:
In axenic and mixed cultures, amphotericin B (25-100 mg/L) was tested for inhibition of selected metabolic activities of algae, fungi, bacteria and zooplankton. Effects of the antibiotic were determined based on inhibition of 14-C-labeled bicarbonate uptake, hydrolysis of the methyl ester of 2,4-dichlorophenoxyacetic acid, growth and acid production. Amphotericin B was dissolved in water by either hydrolyzing the antibiotic or mixing it with sodium deoxycholate. Treatments of mixed suspended microbial communities with 200 mg/L of amphotericin B for at least 15 min was effective for differentiating prokaryotic (bacterial) from eukaryotic (algae and fungi, but not zooplankton) activities.